Health - Google News: Peregrine doubles lung cancer survival in small trial - Reuters

Health - Google News Google News

Peregrine doubles lung cancer survival in small trial - Reuters Sep 7th 2012, 16:00 Peregrine doubles lung cancer survival in small trial Reuters (Reuters) - A mid-stage trial of Peregrine Pharmaceuticals Inc's experimental drug bavituximab showed that it doubled the length of time lung cancer patients survived, supporting the company's plans to conduct a pivotal-stage study. The Phase 2 trial, ... Peregrine Pharma (PPHM) Reports Statistically Significant Data from ...StreetInsider.com (subscription) Bulls, Bears Gird for Fight Over Peregrine's Controversial Lung Cancer DrugTheStreet.com Interim Data From Peregrine's Phase II Trial in Second-Line Non-Small Cell ...MarketWatch (press release) Minyanville.com all 15 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: